September 13, 2024
TOPLINE: In a consensus survey study, participants with atopic dermatitis (AD) agreed on a patient-centered definition of AD flare, which most agreed would help when communicating […]
September 12, 2024
HUNTINGTON BEACH, Calif. — When Roxana Daneshjou, MD, PhD, began reviewing responses to an exploratory survey she and her colleagues created on dermatologists’ use of large […]
September 12, 2024
TOPLINE: Reports of blood and lymphatic disorders were higher in pediatric patients treated with Janus kinase (JAK) inhibitors than in adults in a review of US […]
September 11, 2024
TOPLINE: Nailfold capillaroscopy identifies distinct changes in capillary density, length, and morphology in patients with conditions such as nail psoriasis, onychomycosis, and retronychia. METHODOLOGY: The single-center, […]
September 6, 2024
The same dye that gives Twinkies their yellowish hue could be the key to invisibility. Applying the dye to lab mice made their skin temporarily transparent, […]
September 6, 2024
CARLSBAD, Calif. — When patients with vitiligo see Jessica Shiu, MD, PhD, for the first time, some mention that prior healthcare providers have told them that […]
September 6, 2024
TOPLINE: Metformin significantly improved symptoms and resulted in hair regrowth in Black women with treatment-refractory central centrifugal cicatricial alopecia (CCCA), in a retrospective case series. METHODOLOGY: […]
September 5, 2024
TOPLINE: Compared with nonveterans, US veterans show a higher prevalence of and risk for skin cancer, sunburn, and certain dermatologic conditions, according to a study. METHODOLOGY: […]
September 5, 2024
CARLSBAD, Calif. — The US Food and Drug Administration (FDA) approvals of tapinarof 1% cream and roflumilast 0.3% cream as treatment options for patients with plaque […]